OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects
Sara Jane Ward, Aron H. Lichtman, Daniele Piomelli, et al.
JNCI Monographs (2021) Vol. 2021, Iss. 58, pp. 78-85
Open Access | Times Cited: 15

Showing 15 citing articles:

Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review
Marianna Pellegrini, Fabio Dario Merlo, E. Agnello, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 226-226
Open Access | Times Cited: 20

Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective
Manamele D. Mashabela, Abidemi Paul Kappo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5659-5659
Open Access | Times Cited: 7

Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Kawthar Safi, Jan Sobieraj, Michał Błaszkiewicz, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 307-307
Open Access | Times Cited: 6

Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy
Sebastian Werngreen Nielsen, Simone Dyring Hasselsteen, Helena Sylow Heilmann Dominiak, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 11, pp. 9441-9451
Closed Access | Times Cited: 21

Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer
Thomanai Lamtha, Nathjanan Jongkon, Tossaporn Lertvanithphol, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 6191-6200
Open Access

Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences
María Victoria Noya-Riobó, Constanza Ágata Miguel, Delia Beatriz Soriano, et al.
Experimental Neurology (2022) Vol. 359, pp. 114232-114232
Closed Access | Times Cited: 16

Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Krzysztof Laudański, Justin Wain
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 558-558
Open Access | Times Cited: 14

Antiemetic effects of sclareol, possibly through 5-HT3 and D2 receptor interaction pathways: In-vivo and in-silico studies
Mehedi Hasan Bappi, Abdullah Al Shamsh Prottay, Khattab Al-Khafaji, et al.
Food and Chemical Toxicology (2023) Vol. 181, pp. 114068-114068
Closed Access | Times Cited: 8

Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
A.J. Carrascosa, Francisco Navarrete, Raquel Saldaña, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6268-6268
Open Access | Times Cited: 2

Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications
Dulexy Solano-Orrala, Dennis A. Silva-Cullishpuma, Eliana Díaz-Cruces, et al.
ACS Applied Bio Materials (2024)
Closed Access | Times Cited: 1

The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells
Ahmad Kadriya, Sarah Forbes-Robertson, Mizied Falah
Molecules (2024) Vol. 29, Iss. 24, pp. 5970-5970
Open Access | Times Cited: 1

Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns
Sonia Samuel, Michael Mark, Micheal Tadros
World Journal of Clinical Cases (2023) Vol. 11, Iss. 18, pp. 4210-4230
Open Access | Times Cited: 2

How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges
Jan Sobieraj, K. Strzelecka, Marcin Sobczak, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4607-4649
Open Access

RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment
Feifei Li, Hang Gong, Xinfei Jia, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1465-1465
Open Access

Cannabinoids in treatment of obstructive sleep apnea syndrome
Paulina Szot, Antoni Krzeski
Medycyna Ogólna i Nauki o Zdrowiu (2022) Vol. 28, Iss. 2, pp. 137-141
Open Access

Page 1

Scroll to top